Neurosense regains compliance with nasdaq's minimum equity requirement

Neurosense in compliance with all nasdaq listing requirements cambridge, mass. , jan. 6, 2025 /prnewswire/ -- neurosense therapeutics ltd.
NDAQ Ratings Summary
NDAQ Quant Ranking